Bridging gaps across the CLL care pathway – Part 1: From Signal to Stratification
By Léon Van Wouwe, Clinical Innovation Director, Volv Global From Signal to Stratification – Reimagining Early CLL Care through Algorithmic
By Léon Van Wouwe, Clinical Innovation Director, Volv Global From Signal to Stratification – Reimagining Early CLL Care through Algorithmic
By Léon Van Wouwe, Clinical Innovation Director, Volv Global A Hidden Cancer in Plain Sight Multiple myeloma (MM) has
How AI-driven insights from RWD accelerate the diagnosis and treatment of undiagnosed patients: A case study in alpha-1 antitrypsin deficiency
Alpha-1 antitrypsin deficiency (AATD), a rare genetic condition, can cause lung disease in adults with symptoms similar to chronic obstructive
